Post-earnings recap
Reported
Tue, Apr 25, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported a strong earnings per share, exceeding expectations by nearly 15%. The stock reacted positively, rising by almost 1%. However, without revenue figures or management commentary, it's difficult to assess the broader implications of this quarter's performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.94 | N/A | +14.77% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.